|
| | Pitavastatin Dihydrobenzophenanthridine Basic information |
| Product Name: | Pitavastatin Dihydrobenzophenanthridine | | Synonyms: | Pitavastatin Dihydrobenzophenanthridine;Pitavastatin Impurity 1;VZEBMUGCZPAAOY-KKKMTZTLSA-N;Pitavastatin Dihydrobenzophenanthridine Impurity;Pitavastatin Impurity 1 Calcium Salt;(3R,5S)-5-(6-cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid;Pitavastatin Dihybenzophenanthridine IMP;Benzo[k]phenanthridine-8-pentanoic acid, 6-cyclopropyl-10-fluoro-7,8-dihydro-β,δ-dihydroxy-, (βR,δS)- | | CAS: | 1187966-91-1 | | MF: | C25H24FNO4 | | MW: | 421.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1187966-91-1.mol |  |
| | Pitavastatin Dihydrobenzophenanthridine Chemical Properties |
| solubility | soluble in DMSO, Water | | form | Solid | | color | Pale Yellow |
| | Pitavastatin Dihydrobenzophenanthridine Usage And Synthesis |
| Uses | (3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic Acid Sodium Salt is an impurity of Pitavastatin (P531000), a competitive inhibitor of HMG-CoA reductase. Antilipemic. |
| | Pitavastatin Dihydrobenzophenanthridine Preparation Products And Raw materials |
|
